California Institute for Quantitative Biosciences
The California Institute for Quantitative Biosciences (QB3) is a partnership between the state of California, private industry, venture capital, and the University of California campuses at Berkeley, San Francisco, and Santa Cruz. QB3 is one of four California Institutes for Science and Innovation established in 2000 to ensure the future of the California economy by promoting research and innovation.
Armed with the quantitative tools integral to physics, chemistry, engineering, and mathematics, QB3's more than 200 researchers explore how biological systems work, from atoms and molecules to cells, organs, and entire organisms.
Using advanced imaging, modeling, and computational tools, these scientists decipher the complex systems involved in living systems, and discover ground-breaking applications for that basic knowledge.
QB3 produces health benefits for consumers, through new diagnostic tools and therapies for cancer, HIV-AIDS, and other diseases, and speeds up the process of taking research from the bench to the bedside by bridging the gap between scientists and clinicians. QB3 also brings significant economic benefits to California business, by partnering with industry and venture capital to accelerate knowledge and technology transfer and stimulate emerging industries.
QB3 researchers enjoy access to world-class instrumentation, technologies, and materials located at UC Berkeley, UC San Francisco, UC Santa Cruz, and nearby Lawrence Berkeley National Laboratory.
Access to these state-of-the-art resources enables scientists and engineers to develop devices, drugs, and therapies that save human lives, as well as technologies to prevent or mitigate environmental damage and improve energy production and use. Research areas include bioengineering and biotechnology, bioinformatics and computational biology, structural and chemical biology, experimental genomics, proteomics, and biochemistry.
To stimulate multidisciplinary research, QB3 sponsors seminars, informal workshops, and large formal symposia. Participants explore their common ground, discover new synergistic opportunities, and help build QB3's rich scientific community.
QB3 is dedicated to training the next generation of scientists, readying them for a world in which solving biology's grand challenges requires a multidisciplinary approach. QB3 educational programs are designed to help students achieve fluency in physics, math, engineering, and chemistry, and expertise in integrating these quantitative sciences with biological research.
New courses and novel programs are under way or in development on all three QB3 campuses, including new degree programs for graduate students in chemical, computational, systems, and synthetic biology. For example, UC Berkeley doctoral students in a wide range of disciplines participate in the Designated Emphasis (DE) in Computational and Genomic Biology, essentially a minor for Ph.D. students. Building on that program, a new doctoral program in Computational Biology has been approved, providing an interdisciplinary program for students from varied backgrounds who want to conduct research at the interface of computational and biological sciences. The program plans to welcome its first cohort in Fall 2013. QB3 also houses the Biophysics Graduate Group, an independent Ph.D. program that trains UC Berkeley graduate students for careers at the interface of the biological and physical sciences.
QB3 fosters research partnerships by identifying potential opportunities for collaboration and support, developing platform technologies, and assisting partners with intellectual property and technology transfer issues. Collaborators come from academia, industry, venture capital, and government agencies. QB3's Industrial Advisory Board, which includes industry and venture capital leaders, provides private sector perspective on QB3's role in the California economy.